[Tumor vaccination in renal cell carcinoma with and without interleukin-2 (IL-2) as adjuvant. A clinical contribution to the development of effective active specific immunization].

Source:http://linkedlifedata.com/resource/pubmed/id/7610516

Download in:

View as

General Info

PMID
7610516